CLASS II ONGOING Device recall · Reported 15 Nov 2023 · FDA Enforcement Report

Azurion IGTS Fixed Systems recalled by Philips North America

Philips North America is recalling Azurion IGTS Fixed Systems, distributed in Puerto Rico. The recall was initiated on 4 Oct 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAzurion 7 M12 465 Azurion 7 M20 702 Azurion 7 M20 942 Azurion 7 M20 948 Azurion 7 M20 503

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0229-2024
FDA event ID
93342
Recalling firm
Philips North America, Cambridge, MA
Classification
Class II
Status
Ongoing
Recall initiated
4 Oct 2023
FDA classified
9 Nov 2023
Reported
15 Nov 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Oct 2023Recall initiated by company
9 Nov 2023Classified by FDA+36 days
15 Nov 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Philips has become aware of an issue with the Philips Integris-Allura, Allura Xper and Azurion systems that have been delivered to Puerto Rico without a warning label and the Source-to-Skin Distance Spacer (Tube-spacer) is missing.

Product as listed by the FDA

Azurion IGTS Fixed Systems

Where it was distributed

United States Territories of Puerto Rico, Guam, and Virgin Islands

Puerto Rico

Questions about this recall

Is Azurion IGTS Fixed Systems recalled?

Yes. Philips North America recalled Azurion IGTS Fixed Systems on 4 Oct 2023. The recall is Class II and its status is Ongoing. Recall number Z-0229-2024.

Why was it recalled?

Philips has become aware of an issue with the Philips Integris-Allura, Allura Xper and Azurion systems that have been delivered to Puerto Rico without a warning label and the Source-to-Skin Distance Spacer (Tube-spacer) is missing.

Which lots are affected?

Azurion 7 M12 465 Azurion 7 M20 702 Azurion 7 M20 942 Azurion 7 M20 948 Azurion 7 M20 503

Where was it sold?

United States Territories of Puerto Rico, Guam, and Virgin Islands

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips North America

All 531

Other Other Medical Devices recalls

All 13,771